Best Antitussive for Dry Cough
For dry cough in adults, dextromethorphan is the recommended first-line antitussive, as it provides effective central cough suppression with a favorable safety profile and is widely available over-the-counter.
Algorithmic Approach to Dry Cough Management
Step 1: Identify the Underlying Cause
The choice of antitussive depends critically on what's causing the cough:
- Upper Respiratory Infection (URI)/Common Cold: Peripheral antitussives have limited efficacy and are NOT recommended 1
- Chronic Bronchitis: Central suppressants (codeine, dextromethorphan) are recommended 1
- Acute Bronchitis: Peripheral suppressants like levodropropizine may be beneficial 1
Step 2: Select the Appropriate Agent
For URI/Common Cold (Most Common Scenario):
- Dextromethorphan is your best option as a central suppressant
- The ACCP guidelines specifically note that codeine is NOT recommended for URI-related cough, only for chronic bronchitis 1
- Peripheral suppressants like levodropropizine have "limited efficacy" and carry a Grade D recommendation (no benefit) for URI 1
For Chronic Bronchitis:
- Both codeine and dextromethorphan are recommended with Grade A evidence 1
- Peripheral suppressants (levodropropizine, moguisteine) also have Grade A recommendations for substantial benefit 1
Step 3: Consider Second-Line Options
If dextromethorphan fails in URI-related dry cough:
- Ipratropium bromide (inhaled anticholinergic) has Grade A evidence for substantial benefit in URI or bronchitis 1
- This is the ONLY inhaled anticholinergic recommended by guidelines 1
When non-opioid antitussives fail:
- Codeine combinations (e.g., codeine + triprolidine) can be considered, showing significant reductions in cough severity, frequency, and nighttime awakenings 2
- However, this should be reserved for refractory cases given opioid-related concerns
Evidence Quality and Nuances
The ACCP guidelines 1 from 2006 remain the highest-quality guideline evidence available, though dated. They emphasize that "relatively few drugs are effective for the nonspecific suppression of cough" and that treatment should be guided by the specific disorder causing the cough.
Important distinction: The guidelines explicitly state that codeine should NOT be used for URI-related cough, only for chronic bronchitis 1. This is a common prescribing error to avoid.
Newer research on levodropropizine 3, 4 shows it may be superior to dextromethorphan in some measures (particularly nighttime awakenings and fewer side effects like somnolence), but the guideline evidence limits its recommendation to bronchitis, not URI 1.
Common Pitfalls to Avoid
- Don't use mucolytics or expectorants for dry cough - these are for productive cough only
- Don't prescribe codeine for common cold/URI - guidelines specifically recommend against this despite common practice 1
- Don't use peripheral suppressants for URI - they have Grade D evidence (no benefit) in this setting 1
- Avoid diphenhydramine as primary antitussive - while mentioned historically, it's not in current primary recommendations and causes significant sedation
Practical Dosing
Dextromethorphan: Standard OTC dosing is 10-20 mg every 4 hours or 30 mg every 6-8 hours (maximum 120 mg/24 hours)
Ipratropium bromide (if needed): 2 puffs (36 mcg) QID via MDI
Codeine (only for chronic bronchitis or refractory cases): Typically 10-20 mg every 4-6 hours